Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Re (RMAX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Re (RMAX) over the last 14 years, with Q3 2025 value amounting to -$7.1 million.

  • Re's Other Non Operating Income rose 1481.3% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.5 million, marking a year-over-year increase of 1225.38%. This contributed to the annual value of -$34.0 million for FY2024, which is 996.38% down from last year.
  • Per Re's latest filing, its Other Non Operating Income stood at -$7.1 million for Q3 2025, which was up 1481.3% from -$7.2 million recorded in Q2 2025.
  • In the past 5 years, Re's Other Non Operating Income registered a high of -$2.0 million during Q1 2021, and its lowest value of -$8.6 million during Q1 2024.
  • For the 5-year period, Re's Other Non Operating Income averaged around -$6.2 million, with its median value being -$7.1 million (2025).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 2713.38% in 2021, then crashed by 10851.68% in 2023.
  • Re's Other Non Operating Income (Quarter) stood at -$3.8 million in 2021, then plummeted by 83.81% to -$7.0 million in 2022, then decreased by 17.4% to -$8.2 million in 2023, then decreased by 3.96% to -$8.6 million in 2024, then rose by 17.42% to -$7.1 million in 2025.
  • Its last three reported values are -$7.1 million in Q3 2025, -$7.2 million for Q2 2025, and -$6.7 million during Q1 2025.